The Ordem dos Médicos warns that a 2025 portaria that set the cost-sharing regime has restricted prescriptions of certain diabetes medications and glucose sensors to specialists, creating “unnecessary barriers” and organisational strain in an already pressured system, Público and Correio da Manhã report. The medical body says limiting prescriptions to specialists in areas such as endocrinology and nutrition risks delaying access for patients who now must see specific consultants. Patients using sensors or new diabetes drugs should check plans with their GP and diabetes care team about local referral routes. Those managing diabetes in Portugal should monitor guidance from their clinic or health centre.
Update: Ordinance No. 170/2025/1 cited in warning
Diário de Notícias and Público identify the measure as Ordinance No. 170/2025/1, saying it confines prescriptions for certain glucose sensors and newer diabetes drugs to a narrow set of specialties (including endocrinology and nutrition), which the Ordem dos Médicos says could delay access and create organisational strain even if the rule aims to control spending.




